McCollaum - Genesis Regenerative

I would like to learn more about Genesis® RPA and the physician practice outline above.

First Name

Last Name *

Date Of Birth

Phone

Street

City

State

Zip Code

Country

Cash Or Finance

Any Chronic Illness or Pain

Any Chronic Illness or Pain Description

</p>
</div></div></div> 		</div></div><footer class="footer-page-content footer_color" id="footer-page"><style type="text/css" data-created_by="avia_inline_auto" id="style-css-av-9hzt8-b422e0f1c05079bf2d1e78f8bffe55be">
.avia-section.av-9hzt8-b422e0f1c05079bf2d1e78f8bffe55be{
background-color:#dddce2;
background-image:unset;
}
</style>
<div id='footercopyrightsection'  class='avia-section av-9hzt8-b422e0f1c05079bf2d1e78f8bffe55be main_color avia-section-small avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  av-desktop-hide av-medium-hide av-small-hide av-mini-hide avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><main  role="main" itemprop="mainContentOfPage"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2931'><div class='entry-content-wrapper clearfix'>
<section  class='av_textblock_section av-lwl4n4kh-c2760ff03a457e08b2e77409488c0658 '   itemscope="itemscope" itemtype="https://schema.org/CreativeWork" ><div class='avia_textblock'  itemprop="text" ><p>© 2025 by Genesis Regenerative, LLC | <a href="https://genesisregenerative.com/terms-and-conditions/">Terms & Conditions</a> | <a href="https://genesisregenerative.com/privacy-policy/">Privacy Policy</a></p>
</div></section>

</div></div></main></div></div>
<style type="text/css" data-created_by="avia_inline_auto" id="style-css-av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4">
.avia-section.av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4{
background-color:#dddce2;
background-image:unset;
}
</style>
<div id='av_section_3'  class='avia-section av-lwqyp6tk-2ef28180086a791fdb640e0528384ad4 main_color avia-section-small avia-no-border-styling  avia-builder-el-2  el_after_av_section  avia-builder-el-last  avia-bg-style-scroll av-minimum-height av-minimum-height-custom av-height-custom  container_wrap fullsize'   data-av_minimum_height_px='50'><div class='container av-section-cont-open' style='height:50px'><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2931'><div class='entry-content-wrapper clearfix'>

</div></div></div> 		</div></div></footer>

</div>

</div>
<a href='#top' title='Scroll to top' id='scroll-top-link' class='avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='up-open' data-av_iconset='svg_entypo-fontello' tabindex='-1' aria-hidden='true'>
	<svg version="1.1" xmlns="http://www.w3.org/2000/svg" width="19" height="32" viewBox="0 0 19 32" preserveAspectRatio="xMidYMid meet" aria-labelledby='av-svg-title-1' aria-describedby='av-svg-desc-1' role="graphics-symbol" aria-hidden="true">
<title id='av-svg-title-1'>Scroll to top</title>
<desc id='av-svg-desc-1'>Scroll to top</desc>
<path d="M18.048 18.24q0.512 0.512 0.512 1.312t-0.512 1.312q-1.216 1.216-2.496 0l-6.272-6.016-6.272 6.016q-1.28 1.216-2.496 0-0.512-0.512-0.512-1.312t0.512-1.312l7.488-7.168q0.512-0.512 1.28-0.512t1.28 0.512z"></path>
</svg>	<span class="avia_hidden_link_text">Scroll to top</span>
</a>

<div class="um-modal-body photo">
		<div class="um-modal-photo"></div>
	</div>
</div>
<script type="speculationrules">
{"prefetch":[{"source":"document","where":{"and":[{"href_matches":"\/*"},{"not":{"href_matches":["\/wp-*.php","\/wp-admin\/*","\/wp-content\/uploads\/*","\/wp-content\/*","\/wp-content\/plugins\/*","\/wp-content\/themes\/enfold-child\/*","\/wp-content\/themes\/enfold\/*","\/*\\?(.+)"]}},{"not":{"selector_matches":"a[rel~=\"nofollow\"]"}},{"not":{"selector_matches":".no-prefetch, .no-prefetch a"}}]},"eagerness":"conservative"}]}
</script>
	<div id="wpcp-error-message" class="msgmsg-box-wpcp hideme"><span>error: </span>Content is protected !!</div>
	<script>
	var timeout_result;
	function show_wpcp_message(smessage)
	{
		if (smessage !== "")
			{
			var smessage_text = '<span>Alert: </span>'+smessage;
			document.getElementById("wpcp-error-message").innerHTML = smessage_text;
			document.getElementById("wpcp-error-message").className = "msgmsg-box-wpcp warning-wpcp showme";
			clearTimeout(timeout_result);
			timeout_result = setTimeout(hide_message, 3000);
			}
	}
	function hide_message()
	{
		document.getElementById("wpcp-error-message").className = "msgmsg-box-wpcp warning-wpcp hideme";
	}
	</script>
		<style>
	@media print {
	body * {display: none !important;}
		body:after {
		content: "You are not allowed to print preview this page, Thank you"; }
	}
	</style>
		<style type="text/css">
	#wpcp-error-message {
	    direction: ltr;
	    text-align: center;
	    transition: opacity 900ms ease 0s;
	    z-index: 99999999;
	}
	.hideme {
    	opacity:0;
    	visibility: hidden;
	}
	.showme {
    	opacity:1;
    	visibility: visible;
	}
	.msgmsg-box-wpcp {
		border:1px solid #f5aca6;
		border-radius: 10px;
		color: #555;
		font-family: Tahoma;
		font-size: 11px;
		margin: 10px;
		padding: 10px 36px;
		position: fixed;
		width: 255px;
		top: 50%;
  		left: 50%;
  		margin-top: -10px;
  		margin-left: -130px;
  		-webkit-box-shadow: 0px 0px 34px 2px rgba(242,191,191,1);
		-moz-box-shadow: 0px 0px 34px 2px rgba(242,191,191,1);
		box-shadow: 0px 0px 34px 2px rgba(242,191,191,1);
	}
	.msgmsg-box-wpcp span {
		font-weight:bold;
		text-transform:uppercase;
	}
		.warning-wpcp {
		background:#ffecec url('https://genesisregenerative.com/wp-content/plugins/wp-content-copy-protector/images/warning.png') no-repeat 10px 50%;
	}
    </style>
<div 
	id="pum-589" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_589"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":589,"slug":"copd-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".pulmonary-copd"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_589" class="pum-title popmake-title">
				COPD Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Pulmonary > COPD (Chronic Obstructive Pulmonary Disease)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>FLT4 – FMS RELATED RECEPTOR TYROSINE KINASE 4<br />
PDB Code: <a href="https://www.rcsb.org/structure/4BSK">4BSK</a><br />
<a href="https://www.rcsb.org/3d-view/4BSK?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2324">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>COPD Protocol Guidance: 3 applications of 1 unit IV and 1 unit NEB</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-586" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_586"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":586,"slug":"proactive-regeneration-ii-high-stress-lifestyle","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".proactive-regeneration-high-stress-lifestyle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_586" class="pum-title popmake-title">
				Proactive Regeneration II – High-Stress Lifestyle			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Proactive Regeneration > High-Stress Lifestyle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Proactive Regeneration II Protocol Guidance: 1 application of 2 units  IV monthly or bi-monthly</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-584" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_584"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":584,"slug":"proactive-regeneration-i-common-lifestyle","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".proactive-regeneration-common-lifestyle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_584" class="pum-title popmake-title">
				Proactive Regeneration I – Common Lifestyle			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Proactive Regeneration > Common Lifestyle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Proactive Regeneration I Protocol Guidance: 1 application of 1 unit IV monthly</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-581" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_581"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":581,"slug":"wrist-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-wrist"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_581" class="pum-title popmake-title">
				Wrist Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Wrist</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wrist Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-579" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_579"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":579,"slug":"thoracic-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_579" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-577" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_577"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":577,"slug":"stellate-ganglion-blocks-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_577" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-575" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_575"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":575,"slug":"shoulder-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-shoulder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_575" class="pum-title popmake-title">
				Shoulder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Shoulder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Shoulder Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-573" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_573"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":573,"slug":"lumbar-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_573" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-571" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_571"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":571,"slug":"knee-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-knee"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_571" class="pum-title popmake-title">
				Knee Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Knee</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Knee Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-569" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_569"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":569,"slug":"hip-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-hip"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_569" class="pum-title popmake-title">
				Hip Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Hip</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hip Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-567" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_567"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":567,"slug":"hand-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-hand"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_567" class="pum-title popmake-title">
				Hand Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Hand</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hand Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-565" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_565"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":565,"slug":"ganglion-impair-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_565" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-563" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_563"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":563,"slug":"foot-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-foot"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_563" class="pum-title popmake-title">
				Foot Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Foot</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Foot Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-561" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_561"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":561,"slug":"facet-joints-protocol-guidance-3","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_561" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-559" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_559"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":559,"slug":"elbow-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-elbow"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_559" class="pum-title popmake-title">
				Elbow Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Elbow</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Elbow Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-556" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_556"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":556,"slug":"cervical-disks-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-cervical-disks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_556" class="pum-title popmake-title">
				Cervical Disks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Cervical Disks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Disks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-554" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_554"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":554,"slug":"ankle-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".orthopedic-ankle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_554" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Orthopedic</a> > Ankle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ankle Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-548" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_548"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":548,"slug":"macular-degeneration-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".ophthalmology-macular-degeneration"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_548" class="pum-title popmake-title">
				Macular Degeneration Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Ophthalmology > Macular Degeneration</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>NTF3 – NEUROTROPHIN 3<br />
PDB Code: <a href="https://www.rcsb.org/structure/3BUK">3BUK</a><br />
<a href="https://www.rcsb.org/3d-view/3BUK?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/4908">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Macular Degeneration Protocol Guidance: 3 applications of 2 units IV and 1 unit IN</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-1945" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_1945"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":1945,"slug":"traumatic-brain-injury-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"extra_selectors":".neurological-traumatic-brain-injury-protocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_1945" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Traumatic Brain Injury Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-546" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_546"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":546,"slug":"thoracic-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_546" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-544" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_544"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":544,"slug":"stroke-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-stroke"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_544" class="pum-title popmake-title">
				Stroke Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Stroke</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stroke Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-542" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_542"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":542,"slug":"stellate-ganglion-blocks-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_542" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA + Nerve Block</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-540" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_540"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":540,"slug":"spinal-cord-injury-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-spinal-cord-injury"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_540" class="pum-title popmake-title">
				Spinal Cord Injury Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Spinal Cord Injury</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Spinal Cord Injury Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-538" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_538"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":538,"slug":"peripheral-neuropathy-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-peripheral-neuropathy"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_538" class="pum-title popmake-title">
				Peripheral Neuropathy Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Peripheral Neuropathy</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Neuropathy Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-536" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_536"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":536,"slug":"depression-addiction-detox-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-depression-addiction-detox"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_536" class="pum-title popmake-title">
				Depression/Addiction/Detox Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Depression/Addiction/Detox</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Depression/Addiction/Detox Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-534" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_534"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":534,"slug":"neurodegenerative-disorder-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-neurodegenerative-disorder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_534" class="pum-title popmake-title">
				Neurodegenerative Disorder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Neurodegenerative Disorder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Neurodegenerative Disorder Protocol Guidance: 4 applications of 1 unit IV and 1 unit IN or CSF</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-527" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_527"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":527,"slug":"facet-joints-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_527" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-524" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_524"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":524,"slug":"cervical-discs-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-cervical-discs"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_524" class="pum-title popmake-title">
				Cervical Discs Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Neurological</a> > Cervical Discs</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Discs Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-521" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_521"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":521,"slug":"wounds-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-wounds"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_521" class="pum-title popmake-title">
				Wounds Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Wounds</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wounds Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-519" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_519"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":519,"slug":"ulcers-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-ulcers"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_519" class="pum-title popmake-title">
				Ulcers Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Ulcers</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ulcers Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-517" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_517"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":517,"slug":"neck-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-neck"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_517" class="pum-title popmake-title">
				Neck Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Neck</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Neck Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-515" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_515"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":515,"slug":"leg-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-leg"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_515" class="pum-title popmake-title">
				Leg Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Leg</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Leg Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-513" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_513"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":513,"slug":"skin-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-skin"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_513" class="pum-title popmake-title">
				Skin Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Skin</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Skin Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-511" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_511"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":511,"slug":"hair-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-hair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_511" class="pum-title popmake-title">
				Hair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Hair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hair Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-509" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_509"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":509,"slug":"face-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-face"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_509" class="pum-title popmake-title">
				Face Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Face</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Face Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-506" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_506"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":506,"slug":"burns-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-burns"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_506" class="pum-title popmake-title">
				Burns Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Burns</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Burns Protocol Guidance: 3 applications of 1 unit IV and 1 unit SQ (per site)<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-503" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_503"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":503,"slug":"anti-aging-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-anti-aging"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_503" class="pum-title popmake-title">
				Anti-Aging Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Anti-Aging</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDF11 – GROWTH DIFFERENTIATION FACTOR 11<br />
PDB Code: <a href="https://www.rcsb.org/structure/5E4G">5E4G</a><br />
<a href="https://www.rcsb.org/3d-view/5E4G?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/10220">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Anti-Aging Protocol Guidance: 1 application of 2 units IV not less often than monthly<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-500" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_500"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":500,"slug":"arm-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cosmetic-arm"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_500" class="pum-title popmake-title">
				Arm Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cosmetic</a> > Arm</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>EGFR – EPIDERMAL GROWTH FACTOR RECEPTOR<br />
PDB Code: <a href="https://www.rcsb.org/structure/7SI1">7SI1</a><br />
<a href="https://www.rcsb.org/3d-view/7SI1?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/1956">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Arm Protocol Guidance: 1 application of 2 units IV not less often than monthly<br />
</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-497" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_497"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":497,"slug":"wrist-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-wrist"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_497" class="pum-title popmake-title">
				Wrist Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Wrist</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Wrist Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-495" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_495"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":495,"slug":"thoracic-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-thoracic"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_495" class="pum-title popmake-title">
				Thoracic Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Thoracic</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thoracic Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-493" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_493"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":493,"slug":"stellate-ganglion-blocks-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-stellate-ganglion-blocks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_493" class="pum-title popmake-title">
				Stellate Ganglion Blocks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Stellate Ganglion Blocks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Stellate Ganglion Blocks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-491" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_491"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":491,"slug":"shoulder-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-shoulder"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_491" class="pum-title popmake-title">
				Shoulder Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Shoulder</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Shoulder Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-489" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_489"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":489,"slug":"lumbar-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_489" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-487" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_487"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":487,"slug":"knee-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-knee"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_487" class="pum-title popmake-title">
				Knee Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Knee</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Knee Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-485" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_485"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":485,"slug":"hip-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-hip"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_485" class="pum-title popmake-title">
				Hip Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Hip</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hip Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-483" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_483"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":483,"slug":"hand-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-hand"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_483" class="pum-title popmake-title">
				Hand Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Hand</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hand Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-481" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_481"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":481,"slug":"ganglion-impair-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_481" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-479" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_479"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":479,"slug":"foot-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-foot"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_479" class="pum-title popmake-title">
				Foot Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Foot</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Foot Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-477" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_477"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":477,"slug":"facet-joints-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-facet-joints"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_477" class="pum-title popmake-title">
				Facet Joints Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Facet Joints</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Facet Joints Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-474" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_474"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":474,"slug":"elbow-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-elbow"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_474" class="pum-title popmake-title">
				Elbow Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Elbow</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Elbow Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-470" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_470"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":470,"slug":"cervical-disks-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-cervical-disks"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_470" class="pum-title popmake-title">
				Cervical Disks Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Cervical Disks</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Cervical Disks Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-467" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_467"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":467,"slug":"ankle-protocol-guidance-chiropractic","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".chiropractic-ankle"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_467" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Chiropractic</a> > Ankle</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>BONE MORPHOGENETIC PROTEIN-7<br />
PDB Code: <a href="https://www.rcsb.org/structure/1BMP">1BMP</a><br />
<a href="https://www.rcsb.org/3d-view/1BMP?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/655">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ankle Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-463" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_463"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":463,"slug":"vasculature-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-vasculature"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_463" class="pum-title popmake-title">
				Vasculature Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Vasculature</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Vasculature Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-459" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_459"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":459,"slug":"myocardial-infarction-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-myocardialinfarction"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_459" class="pum-title popmake-title">
				Myocardial Infarction Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Myocardial Infarction</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Myocardial Infarction Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-455" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_455"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":455,"slug":"peripheral-arterial-disease-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-peripheralarterialdisease"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_455" class="pum-title popmake-title">
				Peripheral Arterial Disease Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Cardiological</a> > Peripheral Arterial Disease</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Arterial Disease Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li style="list-style-type: none;">
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
</ul>
<p></ul class=”cutome-font”></li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong>Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-443" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_443"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":443,"slug":"peripheral-neuropathy-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".cardiological-peripheralneuropathy"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_443" class="pum-title popmake-title">
				Peripheral Neuropathy Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > Cardiological > Peripheral Neuropathy</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>VEGFA – VASCULAR ENDOTHELIAL GROWTH FACTOR A<br />
PDB Code: <a href="https://www.rcsb.org/structure/6ZFL">6ZFL</a><br />
<a href="https://www.rcsb.org/3d-view/6ZFL?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/7422">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Peripheral Neuropathy Protocol Guidance: 3 applications of 1 unit IV and 1 unit IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-1861" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_1861"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":1861,"slug":"parkinsons-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"extra_selectors":".auto-immune-parkinson"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_1861" class="pum-title popmake-title">
				Parkinson’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Parkinson’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Parkinson’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-439" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_439"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":439,"slug":"thyroid-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-thyroidprotocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_439" class="pum-title popmake-title">
				Thyroid Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Thyroid</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Thyroid Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-432" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_432"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":432,"slug":"rheumatoid-arthritis-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-rheumatoidarthritis"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_432" class="pum-title popmake-title">
				Rheumatoid Arthritis Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Rheumatoid Arthritis (RA)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code:<a href="https://www.rcsb.org/structure/1ALU"> 1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Rheumatoid Arthritis Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-428" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_428"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":428,"slug":"multiple-sclerosis-ms-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-multiplesclerosis"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_428" class="pum-title popmake-title">
				Multiple Sclerosis (MS) Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Multiple Sclerosis (MS)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Multiple Sclerosis Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-423" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_423"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":423,"slug":"irritable-bowel-syndrome-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-irritablebowel"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_423" class="pum-title popmake-title">
				Irritable Bowel Syndrome Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Irritable Bowel Syndrome (IBS) </strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Irritable Bowel Syndrome Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-420" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_420"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":420,"slug":"hashimotos-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-hashimotos"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_420" class="pum-title popmake-title">
				Hashimoto’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Hashimoto’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Hashimoto’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-417" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_417"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":417,"slug":"fibromyalgia-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-fibromyalgia"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_417" class="pum-title popmake-title">
				Fibromyalgia Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Fibromyalgia</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Fibromyalgia Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-412" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_412"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":412,"slug":"diabetes-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-diabetes"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_412" class="pum-title popmake-title">
				Diabetes Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-immune</a> > Diabetes</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Diabetes Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-397" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_397"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":397,"slug":"autism-non-acute","theme_id":326,"cookies":[],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-autism-non"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_397" class="pum-title popmake-title">
				Autism (Non-Acute) Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Autism (Non-Acute)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<p><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></p>
</div>
<div class="popupdetailheader"><strong>Autism (Non-Acute) Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-407" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_407"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":407,"slug":"crohns-protocol-guidance","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-crohns"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_407" class="pum-title popmake-title">
				Crohn’s Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font"><a href="https://asciere.com/Specialties/">Specialties</a> > <a href="https://asciere.com/auto-immune-protocols/">Auto-Immune</a> > Crohn’s</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Crohn’s Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-335" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_335"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":335,"slug":"autism-acute","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".auto-immune-autism"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_335" class="pum-title popmake-title">
				Ankle Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Auto-Immune > Autism (Acute)</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>IL6 – INTERLEUKIN 6<br />
PDB Code: <a href="https://www.rcsb.org/structure/1ALU">1ALU</a><br />
<a href="https://www.rcsb.org/3d-view/1ALU?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/3569">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol">
<p><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></p>
</div>
</div>
<div class="popupdetailheader"><strong>Autism (Acute) Protocol Guidance: 4 applications of 2 units IV</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>*Lumbar puncture for severe older patients</li>
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-603" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_603"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":603,"slug":"custom-protocol","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".advanced-protocols-custom-protocol"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_603" class="pum-title popmake-title">
				Custom Protocol			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Advanced Protocols > Custom Protocol</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">Among key components, should optimally include:<br />
TNFRSF1B – TNF RECEPTOR SUPERFAMILY MEMBER 1B<br />
PDB Code: <a href="https://www.rcsb.org/structure/3ALQ">3ALQ</a><br />
<a class="cutome-font" style="color:#6464f2;" href="https://www.rcsb.org/3d-view/3ALQ?preset=validationReport">3D Model</a><br />
<a class="cutome-font"  style="color:#6464f2;" href="https://pubchem.ncbi.nlm.nih.gov/gene/7133">Source – National Institute of Health > National Library of Medicine</a></div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Custom Protocol Guidance</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-529" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_529"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":529,"slug":"ganglion-impair-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-ganglion-impair"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_529" class="pum-title popmake-title">
				Ganglion Impair Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Neurological > Ganglion Impair</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Ganglion Impair Protocol Guidance: 3 applications of 4cc IV and 4cc IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<div 
	id="pum-532" 
	role="dialog" 
	aria-modal="false"
	aria-labelledby="pum_popup_title_532"
	class="pum pum-overlay pum-theme-326 pum-theme-default-theme popmake-overlay click_open" 
	data-popmake="{"id":532,"slug":"lumbar-protocol-guidance-2","theme_id":326,"cookies":[{"event":"on_popup_close","settings":{"name":"pum-335","key":"","session":false,"path":"1","time":"1 month"}}],"triggers":[{"type":"click_open","settings":{"cookie_name":"","extra_selectors":".neurological-lumbar"}}],"mobile_disabled":null,"tablet_disabled":null,"meta":{"display":{"stackable":false,"overlay_disabled":false,"scrollable_content":false,"disable_reposition":false,"size":"medium","responsive_min_width":"0%","responsive_min_width_unit":false,"responsive_max_width":"100%","responsive_max_width_unit":false,"custom_width":"640px","custom_width_unit":false,"custom_height":"380px","custom_height_unit":false,"custom_height_auto":false,"location":"center","position_from_trigger":false,"position_top":"100","position_left":"0","position_bottom":"0","position_right":"0","position_fixed":false,"animation_type":"fade","animation_speed":"350","animation_origin":"center top","overlay_zindex":false,"zindex":"1999999999"},"close":{"text":"","button_delay":"0","overlay_click":false,"esc_press":false,"f4_press":false},"click_open":[]}}">

<div id="pum_popup_title_532" class="pum-title popmake-title">
				Lumbar Protocol Guidance			</div>
		
		
				<div class="pum-content popmake-content" tabindex="0">
			<p><strong class="popuptitle cutome-font">Specialties > Neurological > Lumbar</strong></p>
<div class="popupheaderrow">
<div class="col cutome-font">
<p>Among key components, should optimally include:</p>
<p>GDNF-GFRALPHA1 COMPLEX<br />
PDB Code: <a href="https://www.rcsb.org/structure/3FUB">3FUB</a><br />
<a href="https://www.rcsb.org/3d-view/3FUB?preset=validationReport">3D Model</a><br />
<a href="https://pubchem.ncbi.nlm.nih.gov/gene/2668">Source – National Institute of Health > National Library of Medicine</a></p>
</div>
<div class="col popupplaceodercol"><img decoding="async" src="https://genesisregenerative.com///wp-content/uploads/2024/05/Genesis-Regenerative-Logo-White_edited.webp" alt="#" /></div>
</div>
<div class="popupdetailheader"><strong>Lumbar Protocol Guidance: 3 applications of 4cc IV and 4cc IA</strong></div>
<div class="popupdetails">
<ul class="cutome-font">
<li>If/as applicable, scaffolding optional but not necessary.</li>
<li>Applications spread over consecutive months unless otherwise specified by clinician.</li>
<li>Application of regenerative therapy commonly has a 3-stage effect over 1-6 months (or longer), depending on environment, genetics, and current health. Common progression as follows:
<ul>
<li>Month 1 – release of proteins for immediate anti-inflammatory and initial regenerative catalysts.</li>
<li>Months 2-4 – ongoing production and expression of proteins from mRNA (naturally occurring regenerative messages) for continued healing.</li>
<li>Months 4-6+ – resident stem and niche quiescent progenitor cells recapitulate vitality, complete their mature phenotype from miRNA and continue the regeneration.</li>
</ul>
</li>
<li>Variables in environment, lifestyle, pharmaceuticals and epigenetics can impact timing and results. Additional applications and adjusted dosages and/or frequency may be required based on such variables and the severity of indication(s).</li>
<li>Protocols are based on science and peer-reviewed publications with particularized emphasis on the established half-lives of each RNA and subsequent proteins they produce before reapplication is necessary.</li>
<li>Regenerative messages naturally process to areas of highest need first and induce a person’s own resident stem and niche quiescent progenitor cells to become and/or heal as they are meant to – for youthful stasis in cartilage, bone, muscle, nerve, adrenals, vasculature, lymphatic, lung, heart, kidney, liver, organs, etc.</li>
<li>Normal activity and pharmaceuticals at discretion of physician.</li>
</ul>
<p><strong class="cutome-font">Protocol guidance is based on available science and peer-reviewed publications. Each clinician must follow their own protocol(s) based on peer-reviewed publications and professional expertise.</strong></p>
</div>
		</div>

<button type="button" class="pum-close popmake-close" aria-label="Close">
			CLOSE			</button>
		
	</div>

</div>
<script>
  window.onload = function() {
      var links = document.querySelectorAll('img, a ,div[title]');
      for (var i = 0; i < links.length; i++) {
          var link = links[i];
          link.onmouseover = function() {
              this.setAttribute("org_title", this.title);
              this.title = "";
          };
          link.onmouseout = function() {
              this.title = this.getAttribute("org_title");
          };
      }
  };
</script>

var disableStrs = [
										'ga-disable-G-J8WCGZY6J4',
									];

/* Function to detect opted out users */
				function __gtagTrackerIsOptedOut() {
					for (var index = 0; index < disableStrs.length; index++) {
						if (document.cookie.indexOf(disableStrs[index] + '=true') > -1) {
							return true;
						}
					}

return false;
				}

/* Disable tracking if the opt-out cookie exists. */
				if (__gtagTrackerIsOptedOut()) {
					for (var index = 0; index < disableStrs.length; index++) {
						window[disableStrs[index]] = true;
					}
				}

/* Opt-out function */
				function __gtagTrackerOptout() {
					for (var index = 0; index < disableStrs.length; index++) {
						document.cookie = disableStrs[index] + '=true; expires=Thu, 31 Dec 2099 23:59:59 UTC; path=/';
						window[disableStrs[index]] = true;
					}
				}

if ('undefined' === typeof gaOptout) {
					function gaOptout() {
						__gtagTrackerOptout();
					}
				}
								window.dataLayer = window.dataLayer || [];

window.MonsterInsightsDualTracker = {
					helpers: {},
					trackers: {},
				};
				if (mi_track_user) {
					function __gtagDataLayer() {
						dataLayer.push(arguments);
					}

function __gtagTracker(type, name, parameters) {
						if (!parameters) {
							parameters = {};
						}

if (parameters.send_to) {
							__gtagDataLayer.apply(null, arguments);
							return;
						}

if (type === 'event') {
														parameters.send_to = monsterinsights_frontend.v4_id;
							var hookName = name;
							if (typeof parameters['event_category'] !== 'undefined') {
								hookName = parameters['event_category'] + ':' + name;
							}

if (typeof MonsterInsightsDualTracker.trackers[hookName] !== 'undefined') {
								MonsterInsightsDualTracker.trackers[hookName](parameters);
							} else {
								__gtagDataLayer('event', name, parameters);
							}
							
						} else {
							__gtagDataLayer.apply(null, arguments);
						}
					}

__gtagTracker('js', new Date());
					__gtagTracker('set', {
						'developer_id.dZGIzZG': true,
											});
					if ( MonsterInsightsLocations.page_location ) {
						__gtagTracker('set', MonsterInsightsLocations);
					}
										__gtagTracker('config', 'G-J8WCGZY6J4', {"forceSSL":"true","link_attribution":"true"} );
															window.gtag = __gtagTracker;										(function () {
						/* https://developers.google.com/analytics/devguides/collection/analyticsjs/ */
						/* ga and __gaTracker compatibility shim. */
						var noopfn = function () {
							return null;
						};
						var newtracker = function () {
							return new Tracker();
						};
						var Tracker = function () {
							return null;
						};
						var p = Tracker.prototype;
						p.get = noopfn;
						p.set = noopfn;
						p.send = function () {
							var args = Array.prototype.slice.call(arguments);
							args.unshift('send');
							__gaTracker.apply(null, args);
						};
						var __gaTracker = function () {
							var len = arguments.length;
							if (len === 0) {
								return;
							}
							var f = arguments[len - 1];
							if (typeof f !== 'object' || f === null || typeof f.hitCallback !== 'function') {
								if ('send' === arguments[0]) {
									var hitConverted, hitObject = false, action;
									if ('event' === arguments[1]) {
										if ('undefined' !== typeof arguments[3]) {
											hitObject = {
												'eventAction': arguments[3],
												'eventCategory': arguments[2],
												'eventLabel': arguments[4],
												'value': arguments[5] ? arguments[5] : 1,
											}
										}
									}
									if ('pageview' === arguments[1]) {
										if ('undefined' !== typeof arguments[2]) {
											hitObject = {
												'eventAction': 'page_view',
												'page_path': arguments[2],
											}
										}
									}
									if (typeof arguments[2] === 'object') {
										hitObject = arguments[2];
									}
									if (typeof arguments[5] === 'object') {
										Object.assign(hitObject, arguments[5]);
									}
									if ('undefined' !== typeof arguments[1].hitType) {
										hitObject = arguments[1];
										if ('pageview' === hitObject.hitType) {
											hitObject.eventAction = 'page_view';
										}
									}
									if (hitObject) {
										action = 'timing' === arguments[1].hitType ? 'timing_complete' : hitObject.eventAction;
										hitConverted = mapArgs(hitObject);
										__gtagTracker('event', action, hitConverted);
									}
								}
								return;
							}

try {
								f.hitCallback();
							} catch (ex) {
							}
						};
						__gaTracker.create = newtracker;
						__gaTracker.getByName = newtracker;
						__gaTracker.getAll = function () {
							return [];
						};
						__gaTracker.remove = noopfn;
						__gaTracker.loaded = true;
						window['__gaTracker'] = __gaTracker;
					})();
									} else {
										console.log("");
					(function () {
						function __gtagTracker() {
							return null;
						}

window['__gtagTracker'] = __gtagTracker;
						window['gtag'] = __gtagTracker;
					})();
									}
			</script>
				
					<script data-category="functional">
											</script>
					<script>'undefined'=== typeof _trfq || (window._trfq = []);'undefined'=== typeof _trfd && (window._trfd=[]),
                _trfd.push({'tccl.baseHost':'secureserver.net'}),
                _trfd.push({'ap':'wpaas'},
                    {'server':'c2cf8940-d322-a2ae-86c6-4d69b3b72159.secureserver.net'},
                    {'pod':'P3NLWPPOD12'},
                    {'storage':'p3cephmah006pod12_data10'},                     {'xid':'45591089'},
                    {'wp':'6.8.1'},
                    {'php':'8.0.30.5'},
                    {'loggedin':'0'},
                    {'cdn':'1'},
                    {'builder':''},
                    {'theme':'enfold'},
                    {'wds':'0'},
                    {'wp_alloptions_count':'827'},
                    {'wp_alloptions_bytes':'427796'},
                    {'gdl_coming_soon_page':'0'}
                                    );
            var trafficScript = document.createElement('script'); trafficScript.src = 'https://img1.wsimg.com/signals/js/clients/scc-c2/scc-c2.min.js'; window.document.head.appendChild(trafficScript);</script>
		<script>window.addEventListener('click', function (elem) { var _elem$target, _elem$target$dataset, _window, _window$_trfq; return (elem === null || elem === void 0 ? void 0 : (_elem$target = elem.target) === null || _elem$target === void 0 ? void 0 : (_elem$target$dataset = _elem$target.dataset) === null || _elem$target$dataset === void 0 ? void 0 : _elem$target$dataset.eid) && ((_window = window) === null || _window === void 0 ? void 0 : (_window$_trfq = _window._trfq) === null || _window$_trfq === void 0 ? void 0 : _window$_trfq.push(["cmdLogEvent", "click", elem.target.dataset.eid]));});</script>
		<script src='https://img1.wsimg.com/traffic-assets/js/tccl-tti.min.js' onload="window.tti.calculateTTI()"></script>
		</body>
</html>